The Oxford COVID-19 vaccine will be distributed in the UK from January 4 if approved, according to a report by the Sunday Telegraph.
The British government has set a goal to vaccinate two million people within two weeks of the spread.
According to the Telegraph, doses contain doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines.
The Oxford vaccine is expected to be approved by the UK’s Medicines and Healthcare Regulatory Agency within the next few days.
Initial trials of the Oxford vaccine have found it to be less effective than the already approved Pfizer and Modern vaccines, which have so far reported 95% and 94.5% efficacy.
SANDERS CALL TRAMP DELAY ON DELIVERY OF THE ‘WHEN’ BILL, WHILE YOU AGREE WITH PUSH FOR $ 2,000 PAYMENTS
AstraZeneca CEO Pascal Soriot has bolstered hopes for the vaccine and promised to publish an article describing how the two-dose vaccine works.
“We think we’ve established the winning formula and how to get effectiveness that is after two doses at everyone else’s,” Soriot told the Sunday Times.
However, the Department of Health said regulators should be given time to examine the results of the Oxford vaccine.
“We must now give the MHRA the time to carry out its important work, and we must wait for its advice,” a health department spokesman said.
The increasing number of hospitalizations across the country, partly due to a variant that is said to spread 70% faster than previous variants of the coronavirus.
CLICK HERE TO GET THE FOX NEWS APP
In a leaked memorandum, Steve Powis, medical director of the NHS, ordered that hospitals be on their guard regarding the new variant and the South African tension.